Key result
US heart transplant procedures rise over the past decade with pediatric one-year mortality reaching ~6%.
Why the study?
Trends in heart transplant listings, procedures, and posttransplant mortality over time in the United States required comprehensive reporting.
Observational
Yes
The 2017 OPTN/SRTR report highlights increasing numbers of heart transplant listings and procedures in the US, alongside improving posttransplant survival rates.
Rising US heart transplant volumes support program expansion; leaves open questions on sustained pediatric survival and equitable access.
In 2017, 3273 heart transplants were performed in the United States. New listings continued to increase, and 3769 new adults were listed for heart transplant in 2017. Over the past decade, posttransplant mortality has declined. The number of new pediatric listings increased over the past decade, as did the number of pediatric heart transplants, although some fluctuation has occurred more recently. New listings for pediatric heart transplants increased from 481 in 2007 to 623 in 2017. The number of pediatric heart transplants performed each year increased from 330 in 2007 to 432 in 2017, slightly fewer than in 2016. Short-term and long-term mortality improved. Among pediatric patients who underwent transplant between 2015-2016, 4.8% had died by 6 months and 6.2% by 1 year.
No takes yet. Share an insight, caveat, or question.
Colvin et al. (2019) conducted an observational in Heart transplant. Heart transplant was evaluated on Pediatric posttransplant mortality at 1 year (2015-2016). Heart transplant listings and procedures increased in the US over the past decade, with pediatric posttransplant mortality reaching 4.8% at 6 months and 6.2% at 1 year for the 2015-2016 cohort.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: